profile patients

LONDON, UK: Oncimmune Holdings has signed an autoantibody profiling agreement with a leading global pharmaceutical company to evaluate the autoantibody profiles of patient samples in various autoimmune diseases. The initial phase of this project, including the reporting of profiled data,…